TRCT
ANRO icon

Tower Research Capital (TRC)’s Alto Neuroscience ANRO Stock Holding History

Tower Research Capital (TRC)’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.46K Sell
65
-1,922
-97% -$35.6K ﹤0.01% 4653
2025
Q4 		$35.4K Sell
1,987
-403
-17% -$5.08K ﹤0.01% 2691
2025
Q3 		$9.61K Sell
2,390
-228
-9% -$756 ﹤0.01% 4020
2025
Q2 		$5.76K Sell
2,618
-1,619
-38% -$3.85K ﹤0.01% 4151
2025
Q1 		$9.15K Buy
4,237
+1,545
+57% +$5.53K ﹤0.01% 3819
2024
Q4 		$11.4K Buy
2,692
+1,464
+119% +$9.14K ﹤0.01% 3720
2024
Q3 		$14K Buy
+1,228
New +$15K ﹤0.01% 3479
2024
Q2 		– Sell
-1,046
Closed -$16.1K – 6054
2024
Q1 		$16.1K Buy
+1,046
New +$16.4K ﹤0.01% 3207

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tower Research Capital (TRC)'s ANRO Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Alto Neuroscience (ANRO) stake by 97% in Q1 2026, selling an estimated $35.6K and leaving 65 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #4653.

Tower Research Capital (TRC) first reported a position in ANRO in Q1 2024 and has held it in 8 quarters since. The position peaked at $35.4K in Q4 2025. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Tower Research Capital (TRC) held 65 shares of Alto Neuroscience worth $1.46K as of Q1 2026.
  • Tower Research Capital (TRC) sold 1,922 Alto Neuroscience shares in Q1 2026, an estimated $35.6K.
  • Alto Neuroscience made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4653 holding.
  • Tower Research Capital (TRC) first reported a position in Alto Neuroscience in Q1 2024 and has held it in 8 quarters since.
  • Tower Research Capital (TRC)'s Alto Neuroscience position peaked at $35.4K in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.